- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Roger Adsett, Shire
S
Roger Adsett
VP and General Manager, Gastroenterology, Shire
NOTED FOR: Strong leadership, building blockbuster brands
VISION: "Explain it so others internalize—not recite—it"
Roger Adsett knows big brands. He cut his teeth at Astra Merck, heading up marketing for Nexium, then moved to England to serve as global brand director for AstraZenica's Symbicort. Now re-settled in the Northeast corridor, he's translating marketing savvy and global know-how to Shire's GI business—with good results. Last year's launch of Lialda sent business soaring, without cannibalizing Pentasa sales. Shire brands now serve more than a quarter of the oral mesalamine market. And with a co-promotion deal signed with TAP, Adsett will bring his blockbuster mindset to the realm of specialty sales.
Roger Adsett
Beyond the Birthrate: The Societal Costs of Maternal Mortality
September 6th 2024Head of Medical Affairs and Outcomes Research at Organon, Charlotte Owens, MD, FACOG, discusses the most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make.
